Tetrahydrobiisoquinoline derivatives by reaction of dopamine with glyoxal: A novel potential degenerative pathway of catecholamines under oxidative stress conditions

被引:10
作者
Manini, P
Panzella, L
Tedesco, I
Petitto, F
Russo, GL
Napolitano, A
Palumbo, A
d'Ischia, M
机构
[1] Univ Naples Federico II, Dept Organ Chem & Biochem, I-80126 Naples, Italy
[2] CNR, Inst Food Sci, I-83100 Avellino, Italy
[3] Staz Zool Anton Dohrn, Biochem & Mol Biol Lab, I-80121 Naples, Italy
关键词
D O I
10.1021/tx034268q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In 0.1 M phosphate buffer, pH 7.4, dopamine reacts with glyoxal, a cytotoxic and genotoxic alpha-oxoaldehyde produced by oxidative degradation of carbohydrates, to give three main products, two of which could be isolated and identified as the isomeric tetrahydrobiisoquinolines 1 and 2 by extensive two-dimensional NMR and mass spectrometric analysis. Time course studies indicated that 1 is the first intermediate in the process and changes slowly to 2 via an unstable species that escaped all efforts at isolation and structural identification. Products 1 and 2 were detected also among the species formed by the interaction of dopamine with oxidized carbohydrates, such as glucose, ribose, and fructose. Mechanistic evidence suggests that the formation of 1 proceeds by an unusual reaction pathway involving intramolecular cyclization of a double Schiff base intermediate followed by glyoxal-induced oxidation of the resulting octahydrobiisoquinoline intermediate (4). Subsequent conversion of 1 to 2 would involve a complex redox mechanism depending on an initial oxidation step. Product 2 was only poorly toxic to PC 12 cells, whereas its methylated derivative 3 was as toxic as salsolinol, an established neurotoxin. Overall, these results throw light on a novel pathway of dopamine modification of potential relevance to the mechanisms underlying neurodegenerative changes in Parkinson's disease and other disorders characterized by a prooxidant state.
引用
收藏
页码:1190 / 1198
页数:9
相关论文
共 62 条
[1]   Accumulation of α-oxoaldehydes during oxidative stress:: A role in cytotoxicity [J].
Abordo, EA ;
Minhas, HS ;
Thornalley, PJ .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (04) :641-648
[2]   Formation of the 1,N2-glyoxal adduct of deoxyguanosine by phosphoglycolaldehyde, a product of 3′-deoxyribose oxidation in DNA [J].
Awada, M ;
Dedon, PC .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (09) :1247-1253
[3]   Neurobiology - Dopamine's reversal of fortune [J].
Blakely, RD .
SCIENCE, 2001, 293 (5539) :2407-2409
[4]   Role of quinones in toxicology [J].
Bolton, JL ;
Trush, MA ;
Penning, TM ;
Dryhurst, G ;
Monks, TJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (03) :135-160
[5]   INHIBITION OF CATECHOL-O-METHYLTRANSFERASE BY 6,7-DIHYDROXY-3,4-DIHYDROISOQUINOLINES RELATED TO DOPAMINE - DEMONSTRATION USING LIQUID-CHROMATOGRAPHY AND A NOVEL SUBSTRATE FOR O-METHYLATION [J].
CHENG, BY ;
ORIGITANO, TC ;
COLLINS, MA .
JOURNAL OF NEUROCHEMISTRY, 1987, 48 (03) :779-786
[6]   Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase [J].
Cucchi, ML ;
Frattini, P ;
Santagostino, G ;
Preda, S ;
Orecchia, G .
PIGMENT CELL RESEARCH, 2003, 16 (02) :111-116
[7]   Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide [J].
Daveu, C ;
Servy, C ;
Dendane, M ;
Marin, P ;
Ducrocq, C .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 1997, 1 (03) :234-243
[8]   NITRATION OF CATECHOLAMINES WITH NITROGEN-OXIDES IN MILD CONDITIONS - A HYPOTHESIS FOR THE REACTIVITY OF NO IN PHYSIOLOGICAL SYSTEMS [J].
DELABRETECHE, ML ;
SERVY, C ;
LENFANT, M ;
DUCROCQ, C .
TETRAHEDRON LETTERS, 1994, 35 (39) :7231-7232
[9]   Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients [J].
Dell'Anna, ML ;
Urbanelli, S ;
Mastrofrancesco, A ;
Camera, E ;
Iacovelli, P ;
Leone, G ;
Manini, P ;
D'Ischia, M ;
Picardo, M .
PIGMENT CELL RESEARCH, 2003, 16 (05) :553-559
[10]   NITRIC OXIDE-INDUCED NITRATION OF CATECHOLAMINE NEUROTRANSMITTERS - A KEY TO NEURONAL DEGENERATION [J].
DISCHIA, M ;
COSTANTINI, C .
BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (07) :923-927